When a dominant negative mutant of AMPK was ectopically expressed in these cells, the expression of c-MYC was enhanced and resistant to metformin, suggesting that the AMPK–FOXO axis is recruited by metformin to suppress cancer stemness in NSCLC/PTX-resistant cells. The gene discussed is MYC; the disease is non-small cell lung carcinoma.